Dr. Chandrasekharan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Hawkins Drive
Iowa City, IA 52242Phone+1 319-356-2148Fax+1 904-244-3634
Education & Training
- Louisiana State University School of MedicineFellowship, Hematology and Medical Oncology, 2013 - 2016
- University of Florida College of Medicine JacksonvilleResidency, Internal Medicine, 2009 - 2012
- Kilpauk Medical CollegeClass of 2007
Certifications & Licensure
- IA State Medical License 2016 - 2026
- TX State Medical License 2024 - 2025
- MN State Medical License 2012 - 2016
- LA State Medical License 2013 - 2015
- FL State Medical License Active through 2013
Clinical Trials
- Futibatinib in Patients With Specific FGFR Aberrations Start of enrollment: 2020 Aug 24
Publications & Presentations
PubMed
- 1 citationsPeptide Receptor Radionuclide Therapy Improves Survival in Patients Who Progress After Resection of Gastroenteropancreatic Neuroendocrine Tumors.Luis C Borbon, Scott K Sherman, Patrick J Breheny, Chandrikha Chandrasekharan, Yusuf Menda
Annals of Surgical Oncology. 2025-02-01 - ASO Visual Abstract: Peptide Receptor Radionuclide Therapy Improves Survival in Patients Who Progress After Resection of Gastroenteropancreatic Neuroendocrine Tumors.Luis C Borbon, Scott K Sherman, Patrick J Breheny, Chandrikha Chandrasekharan, Yusuf Menda
Annals of Surgical Oncology. 2025-02-01 - 12 citationsSurgical Management of Neuroendocrine Tumor Liver Metastases.Catherine G Tran, Scott K Sherman, Chandrikha Chandrasekharan, James R Howe
Hematology/oncology Clinics of North America. 2025-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: